Beijing Jingyu Yimei Biological Technology Co., Ltd.
PrivateLast Round
IPO
Jun 30, 2023
Est. Valuation
$183.49M
Total Funding Raised
$21.3M
Company Overview
Beijing Jingyu Yimei Biological Technology Co., Ltd. is a biotechnology company that provides and develops biomaterials for the medical beauty industry, focusing on products like subcutaneous injection fillers.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Biotechnology
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beijing Jingyu Yimei Biological Technology Co., Ltd. Comparables
Compare Beijing Jingyu Yimei Biological Technology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tellgen Corporation | 82% | |
| Guangdong Hybribio Biotech Co Ltd | 79% | |
| Dirui Industrial Co Ltd | 79% |
Beijing Jingyu Yimei Biological Technology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Jun 30, 2023 | ||||
| VC Round | Dec 1, 2020 | ||||
| Corporate Funding | Sep 23, 2019 |
Beijing Jingyu Yimei Biological Technology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CITIC Securities Co., Ltd. | IPO |
| 安徽国元资本有限责任公司 | VC Round |
| 中国电气装备集团投资有限公司 | Corporate Funding |
| Anhui Guoyuan Fund Management | Corporate Funding |
| Guoyuan Equity Investment | VC Round |
| CETC Investment Holdings Co., Ltd. | Corporate Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 30, 2023
$178M IPO round led by CITIC Securities
- Dec 1, 2020
$18.35M raised from Guoyuan Equity Investment and others.
Beijing Jingyu Yimei Biological Technology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Beijing Jingyu Yimei Biological Technology Co., Ltd.'s valuation, stock price, and market status.
Is Beijing Jingyu Yimei Biological Technology Co., Ltd. a public or private company?
Beijing Jingyu Yimei Biological Technology Co., Ltd. is a private company.
What is the current stock price of Beijing Jingyu Yimei Biological Technology Co., Ltd.?
Beijing Jingyu Yimei Biological Technology Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Beijing Jingyu Yimei Biological Technology Co., Ltd. worth (valuation)?
Beijing Jingyu Yimei Biological Technology Co., Ltd.'s valuation is estimated at $183.5M based on funding round data.
Can I buy Beijing Jingyu Yimei Biological Technology Co., Ltd. stock?
Beijing Jingyu Yimei Biological Technology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Beijing Jingyu Yimei Biological Technology Co., Ltd.'s last funding round?
Beijing Jingyu Yimei Biological Technology Co., Ltd.'s most recent funding round was IPO on December 1, 2020.
Who are the main investors in Beijing Jingyu Yimei Biological Technology Co., Ltd.?
Key investors in Beijing Jingyu Yimei Biological Technology Co., Ltd. include CITIC Securities Co., Ltd..
Will Beijing Jingyu Yimei Biological Technology Co., Ltd. IPO soon?
No public IPO plans have been announced for Beijing Jingyu Yimei Biological Technology Co., Ltd..
How can I track Beijing Jingyu Yimei Biological Technology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Beijing Jingyu Yimei Biological Technology Co., Ltd.'s secondary market activity and sign up for updates.